Getting Back On Track: Optimizing Site And Patient Engagement In An Oncology Transition Study

During Phase 2 of their oncology program, a small biotech company faced significant challenges with their study, including sluggish recruitment, inadequate site engagement, and delays in data entry, all under the management of their existing Contract Research Organization (CRO). Understanding the potential threat these issues posed to the success of their study, the sponsor decided to seek a new CRO to help revitalize the program and advance the research.
Worldwide Clinical Trials was chosen to take over and revamp the struggling study. In less than 90 days, Worldwide Clinical Trials executed a smooth and efficient transition, carried out a comprehensive feasibility assessment, and swiftly got the study back on track. Their rapid intervention and expertise ensured that the program’s operations were restored and optimized, significantly improving its chances of success.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.